Navigation Links
Streamline Temporary Pacing Leads Premium 6500
Unipolar Temporary Myocardial Pacing Lead

ProductsStreamline Temporary Pacing Leads Premium 6500
Unipolar Temporary Myocardial Pacing Lead
Company Medtronic Inc.
Item Streamline Temporary Pacing Leads Premium 6500
Unipolar Temporary Myocardial Pacing Lead
Features 
  • Gold standard in unipolar temporary pacing leads
  • New relaxed fixation coil minimizes trauma during pacing lead insertion
  • Diameter of the curved myocardial needle has been reduced from 0.66mm to 0.61mm to minimize tissue perforation
  • Discrete electrode for consistent sensing and pacing
  • Easy-to-use breakaway chest needle has been reduced in diameter from 1.00mm to 0.86mm to minimize perforation
  • Silastic fixation disc for atrial placement
  • NEW connector pin sleeves insulate connector pins while not in use
Description Medtronic presents the Streamline family of temporary sensing and pacing leads. Our engineers have taken the gold standard in temporary pacing leads and improved upon the features that make them easy to use and less traumatic to heart tissue.

The Model 6491 Unipolar Pediatric Temporary Pacing Lead is designed for temporary atrial and ventricular sensing and pacing during and after cardiac surgery. This temporary pacing lead has been downsized, making it the ideal lead for pediatric patients or small hearts.

All Medtronic temporary pacing leads are compatible with Medtronic external pulse generators. Integrating more than 50 years of scientific and technological pacing expertise into our temporary pacing leads, Streamline leads are the leads you can trust.

Info Medtronic Inc.
Customer Service: (800) 551-5544
Web site: http://www.medtronic.com/

Related medicine products :

1. Streamline Temporary Pacing Leads Premium 6500 Unipolar Temporary Myocardial Pacing Lead
2. Streamline Temporary Pacing Leads Pediatric 6491 Unipolar Pediatric Temporary Pacing Lead
3. Streamline Temporary Pacing LeadsBipolar Coaxial 6495 Bipolar Temporary Myocardial Pacing Lead
4. Streamline Temporary Pacing Leads Convenience 6494 Unipolar Temporary Myocardial Pacing Wire
5. Streamline Temporary Pacing Leads Atrial 6492 Unipolar Temporary Atrial Pacing Lead
6. Temporary Collagen Plugs
7. Sundt Slim-Line Temporary Aneurysm Clip
8. Temporary Pacing Leads
9. Model 3085 Dual-Chamber Temporary Pacemaker
10. Dual-Chamber Model 5388 External (Temporary) Pulse Generator
11. Model 3077 Single-Chamber Temporary Pacemaker
Breaking Medicine Technology:Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3FDA Launches Orphan Drug Workshop at KGI 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 1Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 2Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 3Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 4Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 5Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 6Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy Five Percent Accrual 4559 1Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy Five Percent Accrual 4559 2Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy Five Percent Accrual 4559 3Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 1Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 2